訊聯 1784.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 1784)
1784 Value Score
3
24
15
Excellent Growth
- AI analysis rates 1784 with the highest value score of 5.
- It is mainly due to stable revenue growth, along with adequate operating cash flow.
- Over the past 3 months, 1784 has maintained an average value rating of 4.7, close to the rating of 4.2 over the past 3 years, indicating stable and increasing opportunities for enterprise value growth.
- Compared to all stocks in the Biotech. & Medical sector, 1784 has a higher value rating.
1784 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/03/21 (Weekly Update)
1784 Financial Forecast
Unit : TWD
Update to 2025/5/9 (Quarterly Update)
1784 Earnings Table
No related data records
1784 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
1784 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 1784 from 2007/07 till Now
- 354.69%
- Cumulative Return
- 9.13%
- Annual Return
- 33.37%
- Volatility
- 0.27
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from July, 2007 to May, 2025. (Total Trades: 4)
| 1784 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | 75% | 46% | 53% |
| Avg Return | 64% | 21.1% | 45.4% |
| Avg Profit | 95.2% | 72.2% | 102.9% |
| Avg Loss | -29.5% | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | 322.4% | 322.8% | 505.8% |
Update to 2025/5/10 (Daily Update)